WOOJUNG BIO Inc (215380) — Cash Flow-to-Debt Ratio
WOOJUNG BIO Inc (215380) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of ₩-809.75 Million could theoretically repay 0% of its total liabilities (₩65.22 Billion) in one year. See WOOJUNG BIO Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
WOOJUNG BIO Inc Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for WOOJUNG BIO Inc across 9 annual periods. Also explore 215380 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for WOOJUNG BIO Inc (2016–2024)
Year-by-year debt coverage analysis for WOOJUNG BIO Inc. For market capitalisation and broader financial context, see 215380 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.02x | ₩-1.13 Billion | ₩65.33 Billion | ▲ +59.1% |
| 2023 | -0.04x | ₩-3.22 Billion | ₩76.36 Billion | ▼ -210.1% |
| 2022 | 0.04x | ₩2.50 Billion | ₩65.28 Billion | ▲ +52.4% |
| 2021 | 0.03x | ₩1.73 Billion | ₩68.68 Billion | ▲ +112.3% |
| 2020 | -0.21x | ₩-8.57 Billion | ₩41.78 Billion | ▼ -3145.0% |
| 2019 | 0.01x | ₩208.72 Million | ₩30.97 Billion | ▲ +132.9% |
| 2018 | -0.02x | ₩-483.80 Million | ₩23.61 Billion | ▲ +88.7% |
| 2017 | -0.18x | ₩-2.38 Billion | ₩13.07 Billion | ▲ +82.1% |
| 2016 | -1.02x | ₩-1.46 Billion | ₩1.43 Billion | — |